Which is better bortezomib or carfilzomib?
The first pre-specified interim analysis showed that patients in the carfilzomib group had higher rates of deeper responses, which translated into significantly longer progression-free survival than those who received bortezomib (median progression-free survival 18·7 months [95% CI 15·6–not estimable] vs 9·4 months [8· …
Is kyprolis better than Velcade?
“We now know that Kyprolis not only significantly extended progression-free survival compared to Velcade, but also overall survival, making it a clinically meaningful advance in the treatment of relapsed or refractory multiple myeloma,” Dr.
How long is maintenance treatment for multiple myeloma?
Most European doctors will have a fixed duration (2-3 years) of maintenance therapy but that could be related to approvals by European regulatory agencies. Most US doctors suggest “until disease progression”.
What is the best maintenance drug for multiple myeloma?
Maintenance treatments containing the immunomodulatory therapy Revlimid (lenalidomide) are the best option for patients with multiple myeloma, according to a recent meta-analysis. The study, “Maintenance Treatment and Survival in Patients With Myeloma,” was published in the journal JAMA Oncology.
What is the maintenance treatment for multiple myeloma?
Targeted therapy is the main type of maintenance therapy for multiple myeloma. Targeted therapy drugs used as maintenance therapy include: lenalidomide (Revlimid) bortezomib (Velcade)
Is Velcade chemo or immunotherapy?
by Drugs.com Velcade is not a traditional form of chemotherapy (chemo). Velcade is a targeted drug therapy in the class of drugs known as proteasome inhibitors. Velcade is an injection often used as a first-line treatment of patients with multiple myeloma.
What is Revlimid maintenance?
Lenalidomide (REVLIMID) is the only FDA-approved maintenance therapy recommended for multiple myeloma by the National Comprehensive Cancer Network® (NCCN®). Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)® for Multiple Myeloma V.1.2022.
What is maintenance chemo for multiple myeloma?
Revlimid (lenalidomide) Revlimid is an oral medication that can stop or slow the growth of cancerous myeloma cells within the bone marrow. Despite the increased risk of causing new cancers in some patients Revlimid continues to be widely used as maintenance therapy in multiple myeloma.
When do you start lenalidomide maintenance?
After autologous stem cell transplant, lenalidomide maintenance can be started after adequate hematologic recovery (absolute neutrophil count ≥ 1,000/µL and/or platelet count ≥ 75,000/µL).
Why is dexamethasone used with Revlimid?
The researchers concluded that, despite lesser anticancer responses, lower doses of dexamethasone used in combination with Revlimid provide better survival than higher-dose dexamethasone used in this treatment combination.
